A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy
Clinical trial NCT04266795 · COMPLETED
Trial details
- NCT number
- NCT04266795
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2022-09-06
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.